In a breakthrough for patients with multi-drug-resistant (MDR) tuberculosis (TB), researchers shared positive trial results for a shorter, tailored...
Vous n'êtes pas connecté
Research Shows Alternative Treatment Regimens Against Drug-resistant TB With tuberculosis (TB) reemerging as the leading infectious disease killer in 2023, new research shows crucial insights and experimental new strategies for treating extensively- drug-resistant TB (XDR TB). The findings of these research were presented at The Union World Conference on Lung Health in Bali, Indonesia. One […]
In a breakthrough for patients with multi-drug-resistant (MDR) tuberculosis (TB), researchers shared positive trial results for a shorter, tailored...
Tuberculosis Resurges as Top Infectious Disease Killer By Joyce Ojanji In the highest tally ever recorded for tuberculosis (TB) cases, the World...
A new antibiotic for tuberculosis (TB) targets multidrug-resistant strains, paving the way for advanced treatments and innovative drug development,...
PAHO News-The World Health Organization (WHO) published a new report on tuberculosis (TB) revealing that globally, approximately 8.2 million people...
GENEVA, Switzerland – The World Health Organization (WHO) published a new report on tuberculosis revealing that approximately 8.2 million people...
Combating Tuberculosis: Bedaquiline, a new TB antibiotic, triumphs over multidrug-resistant strains.
This week, experts and policymakers are convening at the Union’s World Conference on Lung Health to discuss tuberculosis (TB), the world’s...
Glioblastoma is the most common – and the most malignant – primary brain tumour in adults. It’s aggressive and incurable. Even with treatment...
Discover how pembrolizumab, an immunotherapy drug, enhances disease-free survival in advanced soft tissue sarcoma, offering a promising treatment...
Discover how pembrolizumab, an immunotherapy drug, enhances disease-free survival in advanced soft tissue sarcoma, offering a promising treatment...